ZenBio, Inc. Licenses an Important Cell Line from Harvard Medical School to Drive Metabolic Disease Research
3/9/2010 12:01:59 PM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio announce that they will be a commercial source for the popular murine 3T3-L1 cell line, which has been fundamental in metabolic disease research for 30 years. Originally derived from Swiss mouse embryo tissue by Dr. Howard Green of the Department of Cell Biology at Harvard Medical School, the 3T3-L1 system has been pivotal in advancing the understanding of basic cellular mechanisms associated with diabetes, obesity and other related disorders.
comments powered by